APA (7th ed.) Citation

G, L., M, S., JJ, F., N, R., S, S., F, B., . . . A, M. (2026). Predictive Value of Sustained Virologic Response at Week 4 in Patients with Hepatitis C Virus Infection Treated with Sofosbuvir/Velpatasvir. Viruses, 18(2), . https://doi.org/10.3390/v18020269

Chicago Style (17th ed.) Citation

G, Landry, et al. "Predictive Value of Sustained Virologic Response at Week 4 in Patients with Hepatitis C Virus Infection Treated with Sofosbuvir/Velpatasvir." Viruses 18, no. 2 (2026). https://doi.org/10.3390/v18020269.

MLA (9th ed.) Citation

G, Landry, et al. "Predictive Value of Sustained Virologic Response at Week 4 in Patients with Hepatitis C Virus Infection Treated with Sofosbuvir/Velpatasvir." Viruses, vol. 18, no. 2, 2026, https://doi.org/10.3390/v18020269.